News - FORMA Therapeutics

Filter

Current filters:

FORMA Therapeutics

Popular Filters

FORMA meets milestones under Boehringer Ingelheim cancer accord

FORMA meets milestones under Boehringer Ingelheim cancer accord

10-01-2014

US drug discovery company FORMA Therapeutics revealed that it has achieved several discovery milestones…

Boehringer IngelheimFORMA TherapeuticsLicensingOncologyPharmaceuticalResearch

Celgene partners with FORMA Thera on drugs targeting protein homeostasis

30-04-2013

Privately-held FORMA Therapeutics has entered into a strategic collaboration agreement with US biotech…

BiotechnologyCelgeneFORMA TherapeuticsLicensingNeurologicalOncologyResearch

Another mega deal for FORMA Therapeutics

11-01-2012

Hot on the heels of its up to $815 million oncology-related deal with Boehringer Ingelheim (The Pharma…

BiotechnologyFORMA TherapeuticsJanssen BiotechJohnson & JohnsonLicensingOncologyPharmaceuticalResearch

FORMA Thera in up to $815 million deal with Boehringer

06-01-2012

Fast-growing US drug discovery firm FORMA Therapeutics has entered into an R&D collaboration with family-owned…

Boehringer IngelheimFORMA TherapeuticsOncologyPharmaceuticalResearch

Roche’s Genentech in preclinical cancer program deal with FORMA Therapeutics

28-06-2011

Cambridge, Massachusetts, USA-based small-molecule therapeutics developer FORMA Therapeutics has entered…

BiotechnologyFORMA TherapeuticsGenentechLicensingOncologyPharmaceuticalRoche

Back to top